$250 | Single User
$500 | Site License
$750 | Global License

Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 12-10-2018]

Published by Global Data: 12 Oct 2018 | 224464 | In Stock

Introduction

Summary

Abbott Laboratories (Abbott) develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s products comprise specialized medicines; medical diagnostic instruments and tests; minimally invasive surgical devices; nutritional supplements for infants, children and adults; and products for veterinary care. It has research and development, manufacturing and administrative facilities across the world. The company markets its products in North America, Latin America, the Caribbean, the Middle East, Europe, Asia-Pacific and Africa. Abbott is headquartered in Abbott Park, Illinois, the US.

Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.

- Business Description - A brief description of the company's operations.

- Key Employees - A list of the key executives of the company.

- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors - A list of the key competitors of the company.

- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents
for Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 12-10-2018]

  • Table of Contents

    Table of Contents 3

    List of Tables 6

    List of Figures 7

    Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

    Abbott Laboratories, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9

    Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

    Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11

    Abbott Laboratories, Medical Devices Deals, 2012 to YTD 2018 13

    Abbott Laboratories, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 14

    Abbott Laboratories, Pharmaceuticals & Healthcare, Deal Details 18

    Asset Purchase 18

    Abbott Labs And Organon BioSciences Plan To Acquire Certain Pharma Assets From Johnson & Johnson 18

    Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For US.5 Million 20

    Abbott Labs Acquires AP214 From Action Pharma For US0 Million 22

    Venture Financing 23

    NeuroGenetic Pharma Raises US{MAINCONTENT}.2 Million In Venture Financing 23

    NeuroGenetic Pharma Secures Investment In Venture Financing 24

    Private Equity 25

    Sanofi Plans to Sell Portfolio of Mature Drugs for USD8.6 Billion 25

    Partnerships 27

    BioPorto Diagnostics Enters Into Licensing Agreement With Abbott Labs 27

    Cipher Pharma and Italmex Enter into Distribution Agreement 28

    Veropharm Enters into Agreement with Bion 29

    Hennepin County Medical Center, University of Minnesota and Abbott Labs Enter into Agreement 30

    AstraZeneca Enters into Co-Development Agreement with Abbott Labs 31

    ALK-Abello Expands Partnership with Abbott Labs 32

    Advanced Biological Enters into Agreement with Abbott for HIV Genotyping Data Analysis Software 33

    Abbott Labs Enters into Co-Development Agreement with US Department of Defense 34

    Abbott Molecular Enters into Co-Development Agreement with Biocartis 35

    Abbott Enters Into Distribution Agreement With WhanIn For Depakote 36

    Astellas Pharma Global Development Enters Into Co-Development Agreement With Abbott Labs For Cytomegalovirus Vaccine Trial 37

    ChemDiv Research Institute Expands Co-Development Agreement with Abbott Labs 38

    biOasis Technologies Enters Into Research Agreement With Abbott Labs 39

    Abbott India Enters Into Joint Venture Agreement With Syngene International 40

    Abbott Enters Into Co-Development Agreement With Galapagos For Autoimmune Disease Drug 41

    DNDi Enters Into Co-Development Agreement With Abbott Labs For Neglected Tropical Diseases 43

    Licensing Agreements 44

    Abbott Molecular Enters into Licensing Agreement with Institut Curie 44

    Novartis Enters into Licensing Agreement with Abbott Vascular for Everolimus 45

    Sepstone Enters into Licensing Agreement with Abbott Labs 47

    Zealand Pharma Enters Into Licensing Agreement With Abbott Labs For AP214 48

    Apricus Biosciences Enters Into Licensing Agreement With Abbott Labs For Vitaros 49

    Abbott India Enters into Licensing Agreement with Bharat Biotech 50

    Equity Offering 51

    Abbott Labs Plans to Raise USD3 Billion in Public Offering of Shares 51

    Abbott Sells stock of Mylan for USD2.29 Billion 52

    AbbVie Spin Out from Abbott Laboratories 53

    Debt Offering 54

    Abbott Labs Raises USD1.33 Billion in Public Offering of 1.5% Bonds Due 2026 54

    Abbott Labs Raises USD1.33 Billion in Public Offering of 0.875% Bonds Due 2023 55

    Abbott Labs Raises USD1.33 Billion in Public Offering of Bonds Due 2020 56

    Abbott Labs Raises USD3 Billion in Public Offering of 3.75% Notes due 2026 57

    Abbott Labs Raises USD1.5 Billion in Public Offering of 3.4% Notes Due 2023 59

    Abbott Labs Raises USD1.65 Billion in Public Offering of 4.75% Notes due 2036 61

    Abbott Labs Raises USD2.85 Billion in Public Offering of 2.9% Notes due 2021 63

    Abbott Labs Raises USD2.85 Billion in Public Offering of 2.35% Notes due 2019 65

    Abbott Labs Raises USD3.25 Billion in Public Offering of 4.9% Notes due 2046 67

    Abbott Labs Raises USD2.5 Billion in Public Offering of 2% Notes Due 2020 69

    Abbott Labs Raises USD750 Million in Public Offering of 2.55% Notes Due 2022 70

    Abbott Labs Raises USD1 Billion in Public Offering of 2.55% Notes Due 2025 71

    Alere Completes Private Placement Of Notes Due 2020 For US5 Million 72

    Alere Completes Private Placement Of Notes Due 2018 For US0 Million 73

    CFR International Completes Public Offering Of Notes For US0 Million 74

    Abbott Completes Private Placement Of Notes Due 2015 For US0 Million 75

    Abbott Completes Private Placement Of Notes Due 2042 For US.6 Billion 76

    Abbott Completes Private Placement Of Notes Due 2015 For US.5 Billion 77

    Abbott Completes Private Placement Of Notes Due 2017 For US Billion 79

    Abbott Completes Private Placement Of Notes Due 2018 For US Billion 80

    Abbott Completes Private Placement Of Notes Due 2022 For US.1 Billion 81

    Asset Transactions 82

    Corona Remedies Acquires Obimet and Thyrocab from Abbott 82

    Abbott India May Sell Low-End Brands 83

    Mylan Acquires Branded Generics Business of Abbott for USD5.3 Billion 84

    Abbott Labs Rumored To Divest Part Of Generic Drug Business 86

    Acquisition 87

    Abbott Labs Acquires Alere 87

    Johnson & Johnson Acquires Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 90

    Optum Acquires Alere Health for USD600 Million 91

    Persivia Acquires Alere Analytics 92

    Abbott Labs Acquires Veropharm from Roman Avdeev for up to USD415 Million 93

    Abbott Labs Acquires CFR Pharma for USD2.9 Billion 94

    Jude Medical Completes Acquisition of NeuroTherm for USD200 Million 96

    GardenHills Completes Acquisition Of Additional 29.09% Interest In Veropharm For US.3 Million 97

    Arriva Medical Acquires Simplex Healthcare 99

    GardenHills To Acquire 47.99% Stake In Verofarm 100

    Pfizer, Novartis And Abbott Labs Reportedly Plan To Bid For Ache Labs 101

    Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 103

    CFR Pharma Acquires Laboratorio Franco Colombiano Lafrancol And Its Subsidiaries 105

    AFK Sistema Plans To Acquire 51.8% Stake In Veropharm From Aptechnaya set' 36,6 106

    Russian Authorities Reject Abbott's Bid To Acquire 62.5% Stake In Petrovax Pharm, Drug Manufacturer 107

    CFR Pharma Acquires 50% Stake In Stellence For US Million 109

    STARLIMS Technologies Acquires Distribution Partners 110

    CFR Pharma Acquires 41.88% Stake In Domesco Medical For US.4 Million 111

    Abbott Laboratories - Key Competitors 112

    Abbott Laboratories - Key Employees 113

    Abbott Laboratories - Locations And Subsidiaries 115

    Head Office 115

    Other Locations & Subsidiaries 115

    Recent Developments 133

    Financial Announcements 133

    Jul 18, 2018: Abbott reports second-Quarter 2018 Results 133

    Apr 18, 2018: Abbott Reports First-Quarter 2018 Results 136

    Jan 24, 2018: Abbott Reports Fourth-Quarter 2017 Results 139

    Oct 18, 2017: Abbott Reports Third-Quarter 2017 Results 142

    Jul 20, 2017: Abbott Reports Second-Quarter 2017 Results 145

    Apr 19, 2017: Abbott Reports First-Quarter 2017 Results 147

    Corporate Communications 149

    Sep 22, 2017: Abbott and the Abbott Fund Provide Million in Additional Relief to Help Families Affected by Hurricane Maria and the Earthquake in Central Mexico 149

    Sep 18, 2017: Abbott and the Abbott Fund Expand Support for Hurricane Relief With Million to Help Families Affected by Hurricane Irma 150

    Aug 29, 2017: Abbott and the Abbott Fund Donate Million to Support Hurricane Harvey Relief Efforts 151

    Government and Public Interest 152

    Jun 25, 2018: Two diabetes medications don’t slow progression of type 2 diabetes in youth 152

    Feb 23, 2017: First Ever Cannabis-Based ETF to Include PharmaCyte Biotech, Abbott Laboratories, and GW Pharmaceuticals 154

    Product News 155

    Apr 18, 2018: Abbott to produce new infertility drug in Russia 155

    Other Significant Developments 156

    Jun 19, 2018: ClearStar Expands Medical Testing with Abbott Laboratories Integration 156

    Appendix 157

    Methodology 157

    About GlobalData 157

    Contact Us 157

    Disclaimer 157

List Of Tables
in Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 12-10-2018]

List of Tables

Abbott Laboratories, Pharmaceuticals & Healthcare, Key Facts, 2017 2

Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

Abbott Laboratories, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 9

Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

Abbott Laboratories, Deals By Therapy Area, 2012 to YTD 2018 11

Abbott Laboratories, Medical Devices Deals, 2012 to YTD 2018 13

Abbott Laboratories, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 14

Abbott Labs And Organon BioSciences Plan To Acquire Certain Pharma Assets From Johnson & Johnson 18

Thoratec Acquires DuraHeart II Ventricular Assist System From Terumo For US.5 Million 20

Abbott Labs Acquires AP214 From Action Pharma For US0 Million 22

NeuroGenetic Pharma Raises US{MAINCONTENT}.2 Million In Venture Financing 23

NeuroGenetic Pharma Secures Investment In Venture Financing 24

Sanofi Plans to Sell Portfolio of Mature Drugs for USD8.6 Billion 25

BioPorto Diagnostics Enters Into Licensing Agreement With Abbott Labs 27

Cipher Pharma and Italmex Enter into Distribution Agreement 28

Veropharm Enters into Agreement with Bion 29

Hennepin County Medical Center, University of Minnesota and Abbott Labs Enter into Agreement 30

AstraZeneca Enters into Co-Development Agreement with Abbott Labs 31

ALK-Abello Expands Partnership with Abbott Labs 32

Advanced Biological Enters into Agreement with Abbott for HIV Genotyping Data Analysis Software 33

Abbott Labs Enters into Co-Development Agreement with US Department of Defense 34

Abbott Molecular Enters into Co-Development Agreement with Biocartis 35

Abbott Enters Into Distribution Agreement With WhanIn For Depakote 36

Astellas Pharma Global Development Enters Into Co-Development Agreement With Abbott Labs For Cytomegalovirus Vaccine Trial 37

ChemDiv Research Institute Expands Co-Development Agreement with Abbott Labs 38

biOasis Technologies Enters Into Research Agreement With Abbott Labs 39

Abbott India Enters Into Joint Venture Agreement With Syngene International 40

Abbott Enters Into Co-Development Agreement With Galapagos For Autoimmune Disease Drug 41

DNDi Enters Into Co-Development Agreement With Abbott Labs For Neglected Tropical Diseases 43

Abbott Molecular Enters into Licensing Agreement with Institut Curie 44

Novartis Enters into Licensing Agreement with Abbott Vascular for Everolimus 45

Sepstone Enters into Licensing Agreement with Abbott Labs 47

Zealand Pharma Enters Into Licensing Agreement With Abbott Labs For AP214 48

Apricus Biosciences Enters Into Licensing Agreement With Abbott Labs For Vitaros 49

Abbott India Enters into Licensing Agreement with Bharat Biotech 50

Abbott Labs Plans to Raise USD3 Billion in Public Offering of Shares 51

Abbott Sells stock of Mylan for USD2.29 Billion 52

AbbVie Spin Out from Abbott Laboratories 53

Abbott Labs Raises USD1.33 Billion in Public Offering of 1.5% Bonds Due 2026 54

Abbott Labs Raises USD1.33 Billion in Public Offering of 0.875% Bonds Due 2023 55

Abbott Labs Raises USD1.33 Billion in Public Offering of Bonds Due 2020 56

Abbott Labs Raises USD3 Billion in Public Offering of 3.75% Notes due 2026 57

Abbott Labs Raises USD1.5 Billion in Public Offering of 3.4% Notes Due 2023 59

Abbott Labs Raises USD1.65 Billion in Public Offering of 4.75% Notes due 2036 61

Abbott Labs Raises USD2.85 Billion in Public Offering of 2.9% Notes due 2021 63

Abbott Labs Raises USD2.85 Billion in Public Offering of 2.35% Notes due 2019 65

Abbott Labs Raises USD3.25 Billion in Public Offering of 4.9% Notes due 2046 67

Abbott Labs Raises USD2.5 Billion in Public Offering of 2% Notes Due 2020 69

Abbott Labs Raises USD750 Million in Public Offering of 2.55% Notes Due 2022 70

Abbott Labs Raises USD1 Billion in Public Offering of 2.55% Notes Due 2025 71

Alere Completes Private Placement Of Notes Due 2020 For US5 Million 72

Alere Completes Private Placement Of Notes Due 2018 For US0 Million 73

CFR International Completes Public Offering Of Notes For US0 Million 74

Abbott Completes Private Placement Of Notes Due 2015 For US0 Million 75

Abbott Completes Private Placement Of Notes Due 2042 For US.6 Billion 76

Abbott Completes Private Placement Of Notes Due 2015 For US.5 Billion 77

Abbott Completes Private Placement Of Notes Due 2017 For US Billion 79

Abbott Completes Private Placement Of Notes Due 2018 For US Billion 80

Abbott Completes Private Placement Of Notes Due 2022 For US.1 Billion 81

Corona Remedies Acquires Obimet and Thyrocab from Abbott 82

Abbott India May Sell Low-End Brands 83

Mylan Acquires Branded Generics Business of Abbott for USD5.3 Billion 84

Abbott Labs Rumored To Divest Part Of Generic Drug Business 86

Abbott Labs Acquires Alere 87

Johnson & Johnson Acquires Abbott Medical Optics from Abbott Laboratories for USD4.32 Billion 90

Optum Acquires Alere Health for USD600 Million 91

Persivia Acquires Alere Analytics 92

Abbott Labs Acquires Veropharm from Roman Avdeev for up to USD415 Million 93

Abbott Labs Acquires CFR Pharma for USD2.9 Billion 94

Jude Medical Completes Acquisition of NeuroTherm for USD200 Million 96

GardenHills Completes Acquisition Of Additional 29.09% Interest In Veropharm For US.3 Million 97

Arriva Medical Acquires Simplex Healthcare 99

GardenHills To Acquire 47.99% Stake In Verofarm 100

Pfizer, Novartis And Abbott Labs Reportedly Plan To Bid For Ache Labs 101

Abbott, Johnson & Johnson And Sanofi Mull Individual Acquisition Of Bausch & Lomb 103

CFR Pharma Acquires Laboratorio Franco Colombiano Lafrancol And Its Subsidiaries 105

AFK Sistema Plans To Acquire 51.8% Stake In Veropharm From Aptechnaya set' 36,6 106

Russian Authorities Reject Abbott's Bid To Acquire 62.5% Stake In Petrovax Pharm, Drug Manufacturer 107

CFR Pharma Acquires 50% Stake In Stellence For US Million 109

STARLIMS Technologies Acquires Distribution Partners 110

CFR Pharma Acquires 41.88% Stake In Domesco Medical For US.4 Million 111

Abbott Laboratories, Key Competitors 112

Abbott Laboratories, Key Employees 113

Abbott Laboratories, Other Locations 115

Abbott Laboratories, Subsidiaries 115

List Of Figures, Charts and Diagrams
in Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 12-10-2018]

List of Figures

Abbott Laboratories, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 8

Abbott Laboratories, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 9

Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 10

Abbott Laboratories, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 11

Abbott Laboratories, Medical Devices Deals, 2012 to YTD 2018 13

Additional Details

Publisher

Global Data

Publisher Information

Reference

224464 | GDPH1255D

Number of Pages

157

Report Format

PDF

Global Data Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Abbott Partnering Deals and Alliances 2010 to 2016
The Partnering Deals and Alliance since 2010 report provides an in-depth insight into the partnering...
01 Oct 2016 by Current Partnering USD $1,495 More Info
Abbott Vascular Inc. - Product Pipeline Analysis, 2016 Update
SummaryAbbott Vascular Inc. (Abbott Vascular), formerly Perclose, Inc., a subsidiary of Abbott Labor...
30 Mar 2016 by Global Data USD $750 More Info
Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
SummaryAbbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures...
09 Mar 2016 by Global Data USD $250 More Info
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review
Abbott Laboratories (ABT) - Financial and Strategic SWOT Analysis Review provides you an in-depth st...
07 Mar 2016 by Global Data USD $125 More Info
Abbott Laboratories (ABT) - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Laboratories (Abbott) is a healthcare company, which discovers, develops, manufactures...
24 Feb 2016 by Global Data USD $250 More Info
Abbott Diabetes Care, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Diabetes Care, Inc. (ADC), formerly TheraSense, Inc. a subsidiary of Abbott Laboratori...
23 Feb 2016 by Global Data USD $250 More Info
Abbott Molecular Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Molecular Inc. (Abbott Molecular), a subsidiary of Abbott Laboratories is a medical di...
23 Feb 2016 by Global Data USD $250 More Info
Abbott Medical Optics, Inc. - Strategic SWOT Analysis Review
Abbott Medical Optics, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into t...
11 Jan 2016 by Global Data USD $125 More Info
Abbott Diabetes Care, Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Diabetes Care, Inc. (ADC)formerly known as TheraSense, Inc., discovers, develops, manu...
15 Oct 2015 by Global Data USD $250 More Info
Abbott Molecular Inc. - Medical Equipment - Deals and Alliances Profile
SummaryAbbott Molecular Inc. (Abbott) is a medical diagnostic company. The company provides molecula...
15 Oct 2015 by Global Data USD $250 More Info

This report is published by Global Data

Download Free Report Summary PDF

Abbott Laboratories (ABT) - Pharmaceuticals & Healthcare - Deals and Alliances Profile [Report Updated: 12-10-2018] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data